Gene fusions in poroma, porocarcinoma and related adnexal skin tumours: An update

T Kervarrec, D Pissaloux, F Tirode… - …, 2024 - Wiley Online Library
Poroma is a benign sweat gland tumour showing morphological features recapitulating the
superficial portion of the eccrine sweat coil. A subset of poromas may transform into …

Vascular tumors of intermediate malignancy: An update

AL Folpe - Human Pathology, 2024 - Elsevier
The term “hemangioendothelioma” is used for endothelial neoplasms of intermediate
malignancy and describes a group of rare neoplasms having biologic behavior falling in …

Giant cell tumors with HMGA2:: NCOR2 fusion: Clinicopathologic, molecular, and epigenetic study of a distinct entity

R Perret, Z Malaka, V Velasco… - The American Journal …, 2023 - journals.lww.com
Giant cell tumors (GCTs) with high mobility group AT-Hook 2 (HMGA2):: nuclear receptor
corepressor 2 (NCOR2) fusion are rare mesenchymal tumors of controversial nosology …

Untying the Gordian knot of composite hemangioendothelioma: Discovery of novel fusions

K Linos, JK Dermawan, M Pulitzer… - Genes …, 2024 - Wiley Online Library
Composite hemangioendothelioma is a rare, locally aggressive, and rarely metastasizing
vascular neoplasm which affects both children and adults. Recently, a number of gene …

Malignant undifferentiated epithelioid neoplasms with MAML2 rearrangements: A clinicopathologic study of seven cases demonstrating a heterogenous entity

JK Dermawan, SE DiNapoli, P Sukhadia… - Genes …, 2023 - Wiley Online Library
Among mesenchymal tumors, MAML2 gene rearrangements have been described in a
subset of composite hemangioendothelioma and myxoinflammatory fibroblastic sarcoma …

YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer

JH Driskill, JK Dermawan… - Annual Review of …, 2024 - annualreviews.org
Gene fusions are well-known drivers of cancer and are potent targets for molecular therapy.
An emerging spectrum of human tumors harbors recurrent and pathognomonic gene fusions …

Recent Advances in the Diagnosis, Pathogenesis, and Management of Myxoinflammatory Fibroblastic Sarcoma

J Nishio, S Nakayama, M Aoki - International journal of molecular …, 2024 - mdpi.com
Myxoinflammatory fibroblastic sarcoma (MIFS) is an infiltrative, locally aggressive fibroblastic
neoplasm of intermediate malignancy that typically arises in the distal extremities of middle …

Back to the future! Selected bone and soft tissue neoplasms with shared genetic alterations but differing morphological and immunohistochemical phenotypes

NK Dashti, CP Schukow, SE Kilpatrick - Human Pathology, 2024 - Elsevier
Bone and soft tissue tumors (BST) are a highly heterogeneous group largely classified by
their line of differentiation, based on their resemblance to their normal counterpart in adult …

Myxofibrosarcoma in adolescents and young adults: a clinicopathologic study of 17 cases

KRA Angulo, S Logan, A Bahrami, I John, SD Billings… - Human Pathology, 2023 - Elsevier
Myxofibrosarcoma is a locally aggressive sarcoma that characteristically arises in the
extremities of older patients. Cases arising at a younger age are rare, leading to diagnostic …

[HTML][HTML] Lipoblastoma-like tumor and fibrosarcoma-like lipomatous neoplasm represent the same entity: a clinicopathologic and molecular genetic study of 23 cases …

JM Gross, R Perret, JM Coindre, F Le Loarer, M Michal… - Modern Pathology, 2023 - Elsevier
Lipoblastoma-like tumor (LLT) is a benign soft tissue tumor demonstrating mixed
morphologic features of lipoblastoma, myxoid liposarcoma, and spindle cell lipoma but …